Inicio>>Signaling Pathways>> Neuroscience>> Pain Research>>Glycerophospho-N-Arachidonoyl Ethanolamine

Glycerophospho-N-Arachidonoyl Ethanolamine (Synonyms: Glycerophosphoanandamide, GlycerophosphoArachidonoyl Ethanolamide, GPNArE)

Catalog No.GC43774

N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities.

Products are for research use only. Not for human use. We do not sell to patients.

Glycerophospho-N-Arachidonoyl Ethanolamine Chemical Structure

Cas No.: 201738-25-2

Tamaño Precio Disponibilidad Cantidad
1mg
114,00 $
Disponible
5mg
518,00 $
Disponible
10mg
918,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities. The different types of NAE can be derived from glycerophospho-linked precursors by the activity of glycerophosphodiesterase 1 (GDE1). Glycerophospho-N-arachidonoyl ethanolamine is the precursor of arachidonoyl ethanolamide (AEA), also known as anandamide. AEA is an endogenous cannabinoid neurotransmitter that binds to both central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors. It inhibits the specific binding of [3H]-HU-243 to synaptosomal membranes with a Ki value of 52 nM, compared to 46 nM for δ9-THC.

Reseñas

Review for Glycerophospho-N-Arachidonoyl Ethanolamine

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Glycerophospho-N-Arachidonoyl Ethanolamine

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.